In fact, companies like Pfizer and Amgen recently have spent more money in buying back their shares to boost their stock price than on R&amp;D, but that's a whole different TED Talk which one day I'd be fascinated to tell you about.
Poduzeća poput Pfizera i Amgena su nedavno potrošile više novca na otkup vlastitih dionica kako bi im podigle cijenu nego na istraživanje i razvoj. To je jedan poseban TED govor koji ću vam jednog dana rado održati.